Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AAREYDRUGS | NSE
-2.27
-3.31%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
19/09/2024
66.39
70.00
70.00
66.00
Aarey Drugs & Pharmaceuticals Limited engages in the manufacture and sale of active pharmaceutical ingredients intermediates and specialty chemicals for various industrial applications in India. The company provides mono methyl and die methyl urea ortho para nitro anisole 2 bromomethyl 1 and 3 dioxalane and uracile as well as active pharma ingredients such as metformin HCL mefenamic acid and doxophylline. It also offers chemicals and solvents including aeromatics chemicals chemical acids chlor alkalies glycols and glycol ethers fiber intermediates acetates and esters and chlorinated solvents as well as industrial alchols ketones amines oleochemicals intermediates olefines phosphates fertilizers monomers and chemicals. The company's pharmaceutical products are used by pharmaceutical formulation manufacturers and pharmaceutical merchant exporters. It also trades in industrial solvents and chemicals. Aarey Drugs & Pharmaceuticals Limited was incorporated in 1990 and is headquartered in Mumbai India.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Price Below SMA10D
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
24.2%1 month
55.7%3 months
47.9%6 months
45.9%34.02
-
1.44
0.24
0.10
18.20
0.47
-
42.72M
1.86B
22.20M
-
0.56
54.10
149.10
3.74
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
9.43
Range1M
15.39
Range3M
29.80
Rel. volume
0.26
Price X volume
3.59M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Mangalam Drugs & Organics Limited | MANGALAM | Drug Manufacturers-Specialty & Generic | 127.32 | 2.02B | -6.02% | n/a | 72.53% |
Bal Pharma Limited | BALPHARMA | Drug Manufacturers-Specialty & Generic | 127.24 | 2.01B | -3.31% | 27.01 | 201.53% |
Krebs Biochemicals & Industries Limited | KREBSBIO | Drug Manufacturers-Specialty & Generic | 90.59 | 1.96B | -2.00% | n/a | -162.25% |
Bafna Pharmaceuticals Limited | BAFNAPH | Drug Manufacturers-Specialty & Generic | 79.14 | 1.89B | 658.33 | 30.17% | |
Lasa Supergenerics Limited | LASA | Drug Manufacturers-Specialty & Generic | 27.12 | 1.36B | -4.57% | n/a | 22.84% |
Ind-Swift Limited | INDSWFTLTD | Drug Manufacturers-Specialty & Generic | 23.81 | 1.29B | -1.37% | 3.23 | -146.78% |
Biofil Chemicals and Pharmaceuticals Limited | BIOFILCHEM | Drug Manufacturers-Specialty & Generic | 77.68 | 1.26B | -7.23% | 197.64 | 2.41% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 166.42 | 1.85B | -3.27% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 93.74 | 1.34B | -3.01% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 36.42 | 1.02B | -1.33% | n/a | 32.70% |
Sagardeep Alloys Limited | SAGARDEEP | Copper | 28.12 | 483.23M | 88.75 | 43.14% | |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 14.67 | 331.86M | -1.48% | n/a | 0.00% |
Suumaya Industries Limited | SUULD | Apparel Retail | 4.93 | 296.65M | -2.38% | n/a | -118.72% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 18.20 | 23.29 | Cheaper |
Ent. to Revenue | 0.47 | 12.02 | Cheaper |
PE Ratio | 34.02 | 47.84 | Cheaper |
Price to Book | 1.44 | 6.55 | Cheaper |
Dividend Yield | - | 0.59 | - |
Std. Deviation (3M) | 47.95 | 40.95 | Par |
Debt to Equity | 0.24 | 0.34 | Cheaper |
Debt to Assets | 0.10 | 0.17 | Cheaper |
Market Cap | 1.86B | 286.13B | Emerging |